NCT01609374

Brief Summary

This is a prospective, concurrently controlled, multi-center study to evaluate the safety and effectiveness of the Spinal Kinetics M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of symptomatic cervical radiculopathy with or without cord compression. Some participating sites will enroll just M6-C patients, while others will enroll just ACDF patients. Patients eligible for study enrollment will present with degenerative cervical radiculopathy requiring surgical intervention, confirmed clinically and radiographically, at one vertebral level from C3 to C7. A total of 243 subjects will be included at up to 20 sites.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
258

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2012

Completed
1.9 years until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

September 18, 2019

Status Verified

March 1, 2019

Enrollment Period

5.7 years

First QC Date

May 24, 2012

Last Update Submit

September 17, 2019

Conditions

Keywords

Spinal Kineticsartificial cervical disccervical radiculopathyACDFneck paincervical spinedegenerative disc disease

Outcome Measures

Primary Outcomes (2)

  • Safety Evaluation through 24 months

    Evaluate the safety by assessing adverse events and neurological function following implantation with the Spinal Kinetics M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF)

    24 months

  • Effectiveness Evaluation through 24 months

    Evaluate the effectiveness using Neck Disability Index (NDI)

    24 months

Secondary Outcomes (1)

  • Effectiveness of the Spinal Kinetics M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF)

    6 weeks, 3 months, 6 months, 12 months, 24 months

Study Arms (2)

M6-C Artificial Cervical Disc

EXPERIMENTAL
Device: M6-C Artificial Cervical Disc

Anterior Cervical Discectomy and Fusion

ACTIVE COMPARATOR
Device: Anterior plate system with corticocancellous allograft bone

Interventions

Total disc replacement

M6-C Artificial Cervical Disc

Cervical fusion

Anterior Cervical Discectomy and Fusion

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of degenerative cervical radiculopathy with or without spinal cord compression requiring surgical treatment at one level from C3 to C7 demonstrated by signs and/or symptoms of disc herniation and/or osteophyte formation (e.g. neck and/or arm pain, radiculopathy, etc.) and is confirmed by patient history and radiographic studies (e.g. MRI, CT, x-rays, etc.)
  • Inadequate response to conservative medical care over a period of at least 6 weeks
  • Neck Disability Index score of ≥ 30% (raw score of ≥ 15/50)
  • Neck or arm pain VAS ≥ 4 on a scale of 0 to 10
  • Willing and able to comply with the requirements of the protocol including follow-up requirements
  • Willing and able to sign a study specific informed consent
  • Skeletally mature and ≥ 18 years old and ≤ 75 years old

You may not qualify if:

  • More than one cervical level requiring surgery
  • Previous anterior cervical spine surgery
  • Axial neck pain as the solitary symptom
  • Previous posterior cervical spine surgery (e.g., posterior element decompression) that destabilizes the cervical spine
  • Advanced cervical anatomical deformity (e.g., ankylosing spondylitis, scoliosis) at the operative or adjacent levels
  • Symptomatic facet arthrosis
  • Less than 4º of motion in flexion/extension at the index level
  • Instability as evidenced by subluxation \> 3 mm at the index or adjacent levels as indicated on flexion/extension x-rays
  • Advanced degenerative changes (e.g., spondylosis) at the index vertebral level as evidenced by bridging osteophytes, central disc height \< 4mm and/or \< 50% of the adjacent normal intervertebral disc, or kyphotic deformity \> 11º on neutral x-rays
  • Severe cervical myelopathy (i.e., Nurick's Classification \> 2)
  • Active systemic infection or infection at the operative site
  • Co-morbid medical conditions of the spine or upper extremities that may affect the cervical spine neurological and/or pain assessment
  • Metabolic bone disease such as osteoporosis that contradicts spinal surgery (for females over 50 and males over 55 years old, or if the score on the Osteoporosis Self-Assessment Test is \< 2, a dual energy x-ray absorptiometry \[DEXA scan\] of the spine is required; if the bone mineral density T-score in the spine is ≤ -2.5 the patient must be excluded)
  • History of an osteoporotic fracture of the spine, hip or wrist
  • History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

RadiculopathyIntervertebral Disc DegenerationNeck Pain

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesSpinal DiseasesBone DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
since the study is concurrently controlled, masking is not possible
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: non-randomized, concurrent ACDF control
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2012

First Posted

June 1, 2012

Study Start

May 1, 2014

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

September 18, 2019

Record last verified: 2019-03